Toggle light / dark theme

The findings of a new study by the University of Liverpool provides further evidence of an approximately 200 million-year long cycle in the strength of the Earth’s magnetic field.

Researchers performed thermal and microwave (a technique which is unique to the University of Liverpool) paleomagnetic analysis on rock samples from ancient lava flows in Eastern Scotland to measure the strength of the geomagnetic field during key time periods with almost no pre-existing, reliable data. The study also analysed the reliability of all of the measurements from samples from 200 to 500 million years ago, collected over the last ~80 years.

They found that between 332 and 416 million years ago, the strength of the geomagnetic field preserved in these rocks was less than quarter of what it is today, and similar to a previously identified period of low magnetic field strength that started around 120 million years ago. The researchers have coined this period “the Mid-Palaeozoic Dipole low (MPDL).”

A Shortfall of Gravitas: SpaceX’s new drone ship detailed

The ship supported its first mission on August 29. This was the 23rd Commercial Resupply Services mission, the latest in a series of launches for NASA that sends cargo to the International Space Station.

A Shortfall of Gravitas is a notable upgrade over previous ships. SpaceX explained during the mission launch livestream that it improves over its predecessors with a fully autonomous operation procedure. That means it can travel to sea, find its position, receive the rocket, grab the rocket with the “octograbber” robot and return it to land — all autonomously.

A similar nuclear waste storage project, proposed in New Mexico by Holtec International Corp., is also awaiting approval by the Nuclear Regulatory Commission. The agency said it expects to make a decision on that proposal in January 2022.


Texas officials vowed to fight a federal regulator’s decision to approve plans to allow thousands of tons of highly radioactive nuclear waste to be stored in oil fields in the state.

In June, San Francisco-based startup Orbit Fab launched a prototype refueling station into Earth’s orbit — but rather than allowing astronauts to venture into deep space, this system is meant to give old satellites a new lease on life.

That’s a compelling idea, and now the company has locked down $10 million in funding to further it. Our planet’s orbit is getting cluttered with old and new satellites, increasing the risks of a collision and adding to an existing space junk problem.

Orbit Fab’s Tenzing Tanker-001, an early prototype satellite fuel tanker, launched into orbit as part of SpaceX’s Transporter-2 rideshare mission on June 30.

Ending the global sanitation crisis — jack sim, founder world toilet organization.


Around 2 billion people worldwide still lack access to the basic tools of improved sanitation (toilets and latrines). One billion people still have to defecate in the open, and at least 10% of the world’s population is thought to consume food irrigated by raw wastewater. An estimated 800,000 children, younger than 5 years of age, perish from diarrhea each year, including conditions related to cholera, dysentery, hepatitis A, typhoid and polio.

Mr. Jack Sim is the Founder of the World Toilet Organization (https://www.worldtoilet.org/), an organization established with the aim to break the taboo around toilets and this global sanitation crisis.

Reducing naturally occurring errors in protein synthesis (production) improves both health and lifespan, finds a new study in simple model organisms led by researchers at UCL and MRC London Institute of Medical Sciences.

The novel findings, published in Cell Metabolism, are the first to demonstrate a direct link between fewer mistakes and longevity.

Explaining the study, lead author Dr. Ivana Bjedov (UCL Cancer Institute), said: We commonly hear about DNA mutations, which can cause cancer, and are considered one of the underlying causes of ageing.

In contrast to the energy balance model, the carbohydrate-insulin model makes a bold claim: overeating isn’t the main cause of obesity. Instead, the carbohydrate-insulin model lays much of the blame for the current obesity epidemic on modern dietary patterns characterized by excessive consumption of foods with a high glycemic load: in particular, processed, rapidly digestible carbohydrates. These foods cause hormonal responses that fundamentally change our metabolism, driving fat storage, weight gain, and obesity.


Perspective published in The American Journal of Clinical Nutrition argues the root causes of the obesity epidemic are more related to what we eat rather than how much we eat.

Statistics from the Centers for Disease Control and Prevention (CDC) show that obesity affects more than 40% of American adults, placing them at higher risk for heart disease, stroke, type 2 diabetes, and certain types of cancer. The USDA’s Dietary Guidelines for Americans 2020 – 2025 further tells us that losing weight “requires adults to reduce the number of calories they get from foods and beverages and increase the amount expended through physical activity.”

This approach to weight management is based on the century-old energy balance model which states that weight gain is caused by consuming more energy than we expend. In today’s world, surrounded by highly palatable, heavily marketed, cheap processed foods, it’s easy for people to eat more calories than they need, an imbalance that is further exacerbated by today’s sedentary lifestyles. By this thinking, overeating, coupled with insufficient physical activity, is driving the obesity epidemic. On the other hand, despite decades of public health messaging exhorting people to eat less and exercise more, rates of obesity and obesity-related diseases have steadily risen.

Citicoline, a drug that is naturally found in the body, is commonly used to treat a number of brain injuries and illnesses. For quite some time, doctors have prescribed it for strokes, vascular dementia, Parkinson’s disease, and general aging of the brain. Patients usually see improvement when taking the drug because the body uses it to create and repair cell membranes and lower the presence of free radicals, as noted in the Clinical Interventions in Aging Journal. (Free radicals, which are unstable molecules, can damage cells in the body and are associated with aging and illness.)

Now, researchers from the NYU Grossman School of Medicine have found evidence that citicoline can also be used to treat glaucoma. Normally, glaucoma is treated by removing fluid buildup in the eye, which creates pressure and wears down the cells in the eye and the nerves connecting to the brain. Though monitoring fluid buildup is important, glaucoma can still worsen after the pressure on the eye has been relieved.